Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1996 Sep;87(9):963–971. doi: 10.1111/j.1349-7006.1996.tb02127.x

Inhibition of Growth and Metastasis of Ovarian Carcinoma by Administering a Drug Capable of Interfering with Vascular Endothelial Growth Factor Activity

Jie Mu 1, Yoshiko Abe 1, Tateki Tsutsui 1, Norihiko Yamamoto 1, Xu‐Guang Tai 1, Ohtsura Niwa 2, Takahiro Tsujimura 3, Bunzo Sato 4, Hiroshi Terano 5, Hiromi Fujiwara 1,✉, Toshiyuki Hamaoka 1
PMCID: PMC5921202  PMID: 8878460

Abstract

The present study investigates the relationship between in vivo growth/metastasis of tumor cells and their capacity to produce the vascular endothelial growth factor (VEGF), as well as the regulation of tumor growth/metastasis using an angiogenesis‐inhibitory drug. Two cloned tumor cell lines designated OV‐LM and OV‐HM were isolated from a murine ovarian carcinoma OV2944. OV‐LM and OV‐HM cells grew in cultures at comparable rates. However, when transplanted s.c. into syngeneic mice, OV‐HM exhibited a faster growth rate and a much higher incidence of metastasis to lymph nodes and lung. Histologically, intense neovascularization was detected in sections of OV‐HM but not of OV‐LM tumor. OV‐HM and OV‐LM tumor cells obtained from in vitro cultures expressed high and low levels of VEGF mRNA, respectively. A difference in VEGF mRNA expression was much more clearly observed between RNAs prepared from fresh OV‐HM and OV‐LM tumor masses: RNA from OV‐HM contained larger amounts of VEGF mRNA, whereas RNA from OV‐LM exhibited only marginal levels of VEGF mRNA. An angiogenesis‐inhibitory drug, FR118487 inhibited the VEGF‐mediated in vitro growth of endothelial cells but did not affect the expression in vitro of VEGF mRNA by OV‐HM tumor cells. Intraperitoneal injections of FR118487 into mice bearing OV‐HM tumors resulted in: (i) a subsequent growth inhibition of primary tumors; (ii) a marked decrease in neovascularization inside tumor masses expressing comparable levels of VEGF mRNA to those detected in control OV‐HM masses; and (iii) almost complete inhibition of metastasis to lymph nodes and lung. These results indicate that growth/metastasis of tumor cells correlates with their VEGF‐producing capacity and that an angiogenesis inhibitor, FR118487, inhibits tumor growth and metastasis through mechanism(s) including the suppression of VEGF function in vivo.

Keywords: Tumor metastasis, Neovascularization, Vascular endothelial growth factor, Anti‐metastatic effect

Full Text

The Full Text of this article is available as a PDF (671.2 KB).

REFERENCE

  • 1.Folkman , J.Tumor angiogenesis . Adv. Cancer Res ., 43 , 175 – 203 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 2.Liotta , L. , Kleinerman , J. and Saidel , G.Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation . Cancer Res ., 34 , 997 – 1004 ( 1974. ). [PubMed] [Google Scholar]
  • 3.Srivastava , A. , Laidler , P. , Davies , R. P. , Horgan , K. and Hughes , L. E.The prognostic significance of tumor vascularity in intermediate‐thickness (0.76–4.0 mm thick) skin melanoma: a quantitative histologic study . Am. J. Pathol ., 133 , 419 – 423 ( 1988. ). [PMC free article] [PubMed] [Google Scholar]
  • 4.Herlyn , M. , Clark , W. H. , Rodeck , U. , Mancianti , M. L. , Jambrosic , J. and Koprowski , H.Biology of tumor progression in human melanocytes . Lab. Invest ., 56 , 461 – 474 ( 1987. ). [PubMed] [Google Scholar]
  • 5.Folkman , J.What is the evidence that tumors are angiogenesis dependent ? J. Natl. Cancer Inst ., 82 , 4 – 6 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 6.Weidner , N. , Semple , J. P. , Welch , W. R. and Folkman , J.Tumor angiogenesis and metastasis correlation in invasive breast carcinoma . N. Engl. J. Med ., 324 , 1 – 8 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 7.Liotta , L. A. , Steeg , P. S. and Stetler‐Stevenson , W. G.Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation . Cell , 64 , 327 – 336 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 8.Blood , C. H. and Zetter , B. R.Tumor interactions with the vasculature: angiogenesis and tumor metastasis . Biochim. Biophys. Acta , 1032 , 89 – 118 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 9.Folkman , J. and Klagsbrun , M.Angiogenic factors . Science , 235 , 442 – 4471987. . [DOI] [PubMed] [Google Scholar]
  • 10.Basilico , C. and Moscatelli , D.The FGF family of growth factors and oncogenes . Adv. Cancer Res ., 59 , 115 – 165 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 11.Folkman , J. and Shing , Y.Angiogenesis . J. Biol. Chem ., 267 , 10931 – 10934 ( 1992. ). [PubMed] [Google Scholar]
  • 12.Plate , K. , Breier , H. G. , Farrell , C. and Risau , W.Platelet‐derived growth factor receptor‐β is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas . Lab. Invest ., 67 , 529 – 534 ( 1992. ). [PubMed] [Google Scholar]
  • 13.Leung , D. W. , Cachianes , G. , Kuang , W. J. , Goeddel , D. V. and Ferrara , N.Vascular endothelial growth factor is a secreted angiogenic mitogen . Science , 246 , 1306 – 1309 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 14.Jakeman , L. B. , Winer , J. , Bennet , G. , Altar , C. A. and Ferrara , N.Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues . J. Clin. Invest ., 89 , 244 – 253 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Conn , G. , Soderman , D. D. , Schaeffer , M. T. , Wile , M. , Hatcher , V. B. and Thomas , K. A.Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma‐derived cell line . Proc. Natl. Acad. Sci. USA , 87 , 1323 – 1327 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Weindel , K. , Marme , D. and Weich , H.AIDS‐associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor . Biochem. Biophys. Res. Commun ., 183 , 1167 – 1174 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 17.Berse , B. , Brown , L. F. , Van‐de‐Water , L. , Dvorak , H. F. and Senger , D. R. , Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors . Mol. Biol. Cell ., 3 , 211 – 220 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Plate , K. H. , Breier , G. , Weich , H. A. and Risau , W.Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature , 359 , 845 – 848 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 19.Kim , K. J. , Li , B. , Winer , J. , Armanini , M. , Gillett , N. , Phillips , H. S. and Ferrara , N.Inhibition of vascular endothelial growth factor‐induced angiogenesis suppresses tumor growth in vivo. Nature , 362 , 841 – 844 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 20.Hashimoto , M. , Niwa , O. , Nitta , Y. , Takeichi , M. and Yokoro , K.Unstable expression of E‐cadherin adhesion molecules in metastatic ovarian tumor cells . Jpn. J. Cancer Res ., 80 , 459 – 463 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Yoshida , T. O. , Haraguchi , S. , Hiyamoto , H. , and Matsuo , T.Recognition of RSV‐induced tumor cells in syngeneic mice and semi‐syngeneic reciprocal hybrid mice . Gann Monogr. Cancer Res ., 23 , 201 – 212 ( 1979. ). [Google Scholar]
  • 22.Otsuka , T. , Ohkawa , T. , Shibata , T. , Oku , T. , Okuhara , M. , Terano , H. , Kohsaka , M. and Imanaka , H.A new potent angiogenesis inhibitor, FR‐118487 . J. Microbiol. Biotechnol ., 1 , 163 – 168 ( 1991. ). [Google Scholar]
  • 23.Chomczynski , P. and Sacchi , N.Single‐step method of RNA isolation by acid guanidinium thiocyanate‐phenol‐chloroform extraction . Anal. Biochem ., 162 , 156 – 159 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 24.Church , G. M. and Gilbert , W.Genomic sequencing . Proc. Natl. Acad. Sci. USA , 81 , 1991 – 1995 ( 1984. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Mu , J. , Zou , J.‐P. , Yamamoto , N. , Tsutsui , T. , Tai , X.‐G. , Kobayashi , M. , Herrmann , S. , Fujiwara , H. , Hamaoka , T.Administration of rIL‐12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes . Cancer Res ., 55 , 4404 – 4408 ( 1995. ). [PubMed] [Google Scholar]
  • 26.Yanai , N. , Matsuya , Y. and Obinata , M.Spleen stromal cell lines selectively support erythroid colony formation . Blood , 74 , 2391 – 2397 ( 1989. ). [PubMed] [Google Scholar]
  • 27.Nonomura , N. , Lu , J. , Tanaka , A. , Yamanishi , H. , Sato , B. , Sonoda , T. and Matsumoto , K.Interaction of androgen‐induced autocrine heparin‐binding growth factor with fibroblast growth factor receptor on androgen‐dependent Shionogi carcinoma 115 cells . Cancer Res ., 50 , 2316 – 2321 ( 1990. ). [PubMed] [Google Scholar]
  • 28.Killough , J. H. , Magill , G. B. and Smith , R. C.The treatment of ambiasis with fumagillin . Science , 115 , 71 – 72 ( 1952. ). [DOI] [PubMed] [Google Scholar]
  • 29.DiPaolo , J. A. , Tarbell , D. S. and Moore , G. E.Studies on the carcinolytic activity of fumagillin and some of its derivatives . Antibiot. Annu ., 541 – 546 ( 19581959. ). [PubMed] [Google Scholar]
  • 30.Ingber , D. , Fujita , T. , Kishimoto , S. , Sudo , K. , Kanamaru , T. , Brem , H. and Folkman , J.Synthetic analogs of fumagillin that inhibit angiogenesis and suppress tumor growth . Nature , 348 , 555 – 557 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 31.Murai , S. , Itoh , F. , Kozai , Y. , Sudo , K. and Kishimoto , S.Chemical modification of fumagillin. I. 6‐O‐Acyl, 6‐O‐sulfonyl, 6‐O‐alkyl and 6‐O‐(N‐substituted carbamoyl) fumagillols . Chem. Pharm. Bull ., 40 , 96 – 101 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 32.Yamaoka , M. , Yamamoto , T. , Masaki , T. , Ikeyama , S. , Sudo , K. and Fujita , T.Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O‐(Choloroacetyl‐carbamoyl) fumagillol (TNP‐470; AGM‐1470) . Cancer Res ., 53 , 4262 – 4267 ( 1993. ). [PubMed] [Google Scholar]
  • 33.Yanase T. , Tamura , M. , Fujita , K. , Kodama , S. and Tanaka , D.Inhibitory effect of angiogenesis inhibitor TNP‐470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res ., 53 , 2566 – 2570 ( 1993. ). [PubMed] [Google Scholar]
  • 34.Yamaoka , M. , Yamamoto , T. , Ikeyama , S. , Sudo , K. and Fujita , T.Angiogenesis inhibitor TNP‐470 (AGM‐1470) potently inhibits the tumor growth of hormone‐independent human breast and prostate carcinoma cell lines . Cancer Res ., 53 , 5233 – 5236 ( 1993. ). [PubMed] [Google Scholar]
  • 35.Toi , M. , Hoshina , S. , Takayanagi , T. and Tominaga , T.Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer . Jpn. J. Cancer Res ., 85 , 1045 – 1049 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Shweiki , D. , Itin , A. , Soffer , D. E. and Keshet , E.Vascular endothelial growth factor induced by hypoxia may mediate hypoxia‐initiated angiogenesis . Nature , 359 , 843 – 845 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 37.Piate , K. H. , Breier , G. , Millauer , B. , Ullrich , A. and Risau , W.Up‐regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis . Cancer Res ., 53 , 5822 – 5827 ( 1993. ). [PubMed] [Google Scholar]
  • 38.Sunderkotter , C. , Steinbrink , K. , Goebeler , M. , Bhardwaj , R. and Sorg , C.Macrophages and angiogenesis . J. Leukocyte Biol ., 55 , 410 – 422 ( 1994. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES